JP2012523573A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012523573A5 JP2012523573A5 JP2012505086A JP2012505086A JP2012523573A5 JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5 JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5
- Authority
- JP
- Japan
- Prior art keywords
- diagnostic method
- disease
- antibiotics
- administration
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002405 diagnostic procedure Methods 0.000 claims 10
- 239000003242 anti bacterial agent Substances 0.000 claims 8
- 229940088710 antibiotic agent Drugs 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 208000031662 Noncommunicable disease Diseases 0.000 claims 5
- 108010048233 Procalcitonin Proteins 0.000 claims 5
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 claims 5
- 238000004393 prognosis Methods 0.000 claims 5
- 239000002243 precursor Substances 0.000 claims 4
- 230000002411 adverse Effects 0.000 claims 3
- 208000037920 primary disease Diseases 0.000 claims 3
- 238000013517 stratification Methods 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157886.4 | 2009-04-14 | ||
| EP09157886 | 2009-04-14 | ||
| PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012523573A JP2012523573A (ja) | 2012-10-04 |
| JP2012523573A5 true JP2012523573A5 (https=) | 2012-11-15 |
| JP5650718B2 JP5650718B2 (ja) | 2015-01-07 |
Family
ID=40886944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012505086A Active JP5650718B2 (ja) | 2009-04-14 | 2010-04-14 | プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9046532B2 (https=) |
| EP (1) | EP2419741B1 (https=) |
| JP (1) | JP5650718B2 (https=) |
| CN (2) | CN105334330A (https=) |
| CY (1) | CY1122202T1 (https=) |
| DK (1) | DK2419741T3 (https=) |
| ES (1) | ES2751105T3 (https=) |
| HK (1) | HK1221766A1 (https=) |
| HR (1) | HRP20191862T1 (https=) |
| HU (1) | HUE046182T2 (https=) |
| LT (1) | LT2419741T (https=) |
| PL (1) | PL2419741T3 (https=) |
| PT (1) | PT2419741T (https=) |
| SI (1) | SI2419741T1 (https=) |
| WO (1) | WO2010118855A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2836841B1 (en) * | 2012-04-12 | 2022-01-05 | B.R.A.H.M.S GmbH | Prognosis of adverse events in patients with suspected chronic heart failure |
| CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
| CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
| JP7444776B2 (ja) * | 2017-12-20 | 2024-03-06 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| ATE395364T1 (de) * | 1999-12-22 | 2008-05-15 | Dade Behring Marburg Gmbh | Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung |
| JP2005522669A (ja) * | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | 卒中および脳損傷の診断マーカーおよびその使用方法 |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
| FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
| DE102006046996A1 (de) * | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| CN103123359B (zh) * | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
-
2010
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en not_active Ceased
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 HR HRP20191862TT patent/HRP20191862T1/hr unknown
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en not_active Revoked
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Behr | The diagnosis and treatment of idiopathic pulmonary fibrosis | |
| Jeschke et al. | Morbidity and survival probability in burn patients in modern burn care | |
| Kalinke et al. | The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers | |
| Innes et al. | Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost‐effectiveness | |
| Corhay et al. | Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross‐sectional multicentre study | |
| Shi et al. | Tumour biomarkers: association with heart failure outcomes | |
| CN101790687A (zh) | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 | |
| EP3482201A1 (en) | Early diagnosis of infections | |
| Dhawan et al. | Predictors of Mortality for Nursing Home‐Acquired Pneumonia: A Systematic Review | |
| Brussino et al. | Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer | |
| JP2012523573A5 (https=) | ||
| Pan et al. | Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis | |
| JP2023111913A (ja) | pro-ADMに基づく抗生物質療法の指導 | |
| Seah et al. | Interleukin-4 and its alternatively spliced variant (IL-4 δ 2) in patients with atopic asthma | |
| Xu et al. | Predictive value of combined LIPS and ANG‐2 level in critically ill patients with ARDS risk factors | |
| Boeckmans et al. | Liver stiffness as a cornerstone in heart disease risk assessment | |
| Schiavetti et al. | Long‐term renal function in unilateral non‐syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols | |
| Bernardes et al. | Myocardial perfusion in rheumatoid arthritis patients: associations with traditional risk factors and novel biomarkers | |
| CN105717146A (zh) | 一种基于ct影像及生物标志物谱针对中国城市人口高危人群的肺癌风险预测试剂盒 | |
| Guervilly et al. | A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia | |
| Lin et al. | Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension | |
| Carmona et al. | Inflammation, myocardial dysfunction, and mortality in children with septic shock: an observational study | |
| JP2017519008A5 (https=) | ||
| JPWO2019117269A1 (ja) | 膵がんの検出を補助する方法 | |
| Wan et al. | Postinfectious bronchiolitis obliterans in children |